Found 47 matching trials
Study to Treat Major Depressive Disorder With a New Medication PHASE2 This project is designed to examine the neuronal KCNQ2/3 potassium (K+) cha...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
Potential Advantages of Robotic Total Gastrectomy in Advanced Middle-Upper Gastric Cancer: A Multicenter Propensity Score Matching Analysis N/A This multicenter retrospective cohort study aimed to evaluate the potential...
Show More Location
Department of Gastric Surgery, Fujian Medical University Union Hospital
Learn More & Join Trial
XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy PHASE3 To investigate the potential antiseizure effects of adjunctive XEN496 (ezog...
Show More Location
Children's Hospital of Orange County
Learn More & Join Trial
Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery NA To evaluate the clinical outcomes of the systemic re-esterified triglycerid...
Show More Location
Multiple Locations
Learn More & Join Trial
Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures PHASE3 The immediate release (IR) formulation of retigabine has been shown to be s...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study in Healthy Adults to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources to One Fish Source and Placebo PHASE3 This is a randomised, double-blind, parallel, placebo-controlled study in h...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures PHASE3 The purpose of this Phase III study is to evaluate the efficacy, safety and...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Treat Major Depressive Disorder (MDD) With a New Medication PHASE2 The purpose of this study is to test the antidepressant effects of Ezogabin...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097 PHASE3 This Phase 3 trial is an open-label extension study of the placebo-controll...
Show More Location
Institute of Clniical Neurosciences
Learn More & Join Trial
Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects PHASE1 The purpose of this study is to investigate the pharmacokinetics of single ...
Show More Location
GSK Investigational Site
Learn More & Join Trial